18-50664008-G-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_002747.4(MAPK4):​c.50G>A​(p.Gly17Asp) variant causes a missense change. The variant allele was found at a frequency of 0.00172 in 1,613,796 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 7 hom. )

Consequence

MAPK4
NM_002747.4 missense

Scores

1
6
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.83
Variant links:
Genes affected
MAPK4 (HGNC:6878): (mitogen-activated protein kinase 4) Mitogen-activated protein kinase 4 is a member of the mitogen-activated protein kinase family. Tyrosine kinase growth factor receptors activate mitogen-activated protein kinases which then translocate into the nucleus and phosphorylate nuclear targets. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.055694282).
BS2
High AC in GnomAd4 at 175 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MAPK4NM_002747.4 linkc.50G>A p.Gly17Asp missense_variant 2/6 ENST00000400384.7 NP_002738.2 P31152

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MAPK4ENST00000400384.7 linkc.50G>A p.Gly17Asp missense_variant 2/61 NM_002747.4 ENSP00000383234.1 P31152
MAPK4ENST00000588540.1 linkc.50G>A p.Gly17Asp missense_variant 2/31 ENSP00000465661.1 K7EN18
MAPK4ENST00000592595.5 linkc.50G>A p.Gly17Asp missense_variant 2/41 ENSP00000466233.1 K7ELV1
MAPK4ENST00000540640.3 linkc.-87-51071G>A intron_variant 2 ENSP00000439231.1 B4DEW2

Frequencies

GnomAD3 genomes
AF:
0.00115
AC:
175
AN:
152204
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00204
Gnomad OTH
AF:
0.000957
GnomAD3 exomes
AF:
0.00105
AC:
262
AN:
249216
Hom.:
1
AF XY:
0.000998
AC XY:
135
AN XY:
135224
show subpopulations
Gnomad AFR exome
AF:
0.000323
Gnomad AMR exome
AF:
0.000927
Gnomad ASJ exome
AF:
0.0000994
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000948
Gnomad FIN exome
AF:
0.000282
Gnomad NFE exome
AF:
0.00165
Gnomad OTH exome
AF:
0.000330
GnomAD4 exome
AF:
0.00178
AC:
2599
AN:
1461474
Hom.:
7
Cov.:
31
AF XY:
0.00173
AC XY:
1256
AN XY:
727026
show subpopulations
Gnomad4 AFR exome
AF:
0.000209
Gnomad4 AMR exome
AF:
0.000872
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000869
Gnomad4 FIN exome
AF:
0.000321
Gnomad4 NFE exome
AF:
0.00212
Gnomad4 OTH exome
AF:
0.00177
GnomAD4 genome
AF:
0.00115
AC:
175
AN:
152322
Hom.:
0
Cov.:
32
AF XY:
0.00111
AC XY:
83
AN XY:
74492
show subpopulations
Gnomad4 AFR
AF:
0.000505
Gnomad4 AMR
AF:
0.000588
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.000188
Gnomad4 NFE
AF:
0.00204
Gnomad4 OTH
AF:
0.000947
Alfa
AF:
0.00167
Hom.:
1
Bravo
AF:
0.00123
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000487
AC:
2
ESP6500EA
AF:
0.00286
AC:
24
ExAC
AF:
0.00109
AC:
132
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00164
EpiControl
AF:
0.00172

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 11, 2024The c.50G>A (p.G17D) alteration is located in exon 2 (coding exon 1) of the MAPK4 gene. This alteration results from a G to A substitution at nucleotide position 50, causing the glycine (G) at amino acid position 17 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.50
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.21
T;T;.
Eigen
Uncertain
0.20
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.73
T;T;T
M_CAP
Benign
0.042
D
MetaRNN
Benign
0.056
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.3
L;.;.
PrimateAI
Uncertain
0.66
T
PROVEAN
Uncertain
-4.1
D;.;.
REVEL
Benign
0.18
Sift
Benign
0.050
D;.;.
Sift4G
Benign
0.27
T;T;T
Polyphen
0.83
P;.;.
Vest4
0.54
MVP
0.89
MPC
1.8
ClinPred
0.025
T
GERP RS
5.7
Varity_R
0.58
gMVP
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34207571; hg19: chr18-48190378; COSMIC: COSV99077665; COSMIC: COSV99077665; API